Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Enlivant Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12367
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assistance with activities of daily living, including dressing, bathing, and dining, nursing oversight, care for chronic conditions, such as diabetes, medication management; housekeeping and laundry, apartment maintenance and repairs and scheduled transportation, among others. The center provides assisted living communities through its apartments located in Arizona, Florida, Georgia, Idaho, Indiana, Iowa, Kentucky, Louisiana, Michigan, Nebraska, New Jersey, Ohio, Oregon, Pennsylvania, South Carolina, Texas, Washington and Wisconsin. Enlivant is headquartered in Chicago, Illinois, the US.

Enlivant Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enlivant Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enlivant Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Enlivant Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Assisted Living Concepts Acquires 12 Seniors Housing Communities From Ventas For US$100 Million 9
Private Equity 10
TPG Capital Completes Acquisition Of Assisted Living Concepts For Up To US$278 Million 10
Asset Transactions 12
FNR South Holland Acquires South Holland Senior Community From Providence Life Services 12
Enlivant Inc – Key Competitors 13
Enlivant Inc – Key Employees 14
Enlivant Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Enlivant Inc, Pharmaceuticals & Healthcare, Key Facts 2
Enlivant Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enlivant Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Enlivant Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Assisted Living Concepts Acquires 12 Seniors Housing Communities From Ventas For US$100 Million 9
TPG Capital Completes Acquisition Of Assisted Living Concepts For Up To US$278 Million 10
FNR South Holland Acquires South Holland Senior Community From Providence Life Services 12
Enlivant Inc, Key Competitors 13
Enlivant Inc, Key Employees 14
Enlivant Inc, Other Locations 15

List of Figures
Enlivant Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Enlivant Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Enlivant Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Riyad Bank:企業の戦略・SWOT・財務分析
    Riyad Bank - Strategy, SWOT and Corporate Finance Report Summary Riyad Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Nutreco NV:企業のM&A・事業提携・投資動向
    Nutreco NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nutreco NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Sunvault Energy Inc:電力:M&Aディール及び事業提携情報
    Summary Sunvault Energy Inc (Sunvault Energy) is a renewable energy company that provides solar energy products and solutions. The company provides products such as solar energy products, renewable energy products, water and sewer equipment, wind power generation equipment, solar power generation eq …
  • ABIONYX Pharma SA (CEREN):企業の財務・戦略的SWOT分析
    Summary ABIONYX Pharma SA (ABIONYX) is a biopharmaceutical company that discovers and develops HDL therapies for the treatment of cardiovascular and metabolic diseases. Its therapies include CER-001 a negatively-charged lipoprotein particle that find application in atheosclerotic plaque regression; …
  • Excelsior Gold Limited (EXG):企業の財務・戦略的SWOT分析
    Excelsior Gold Limited (EXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Cingulate Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cingulate Therapeutics LLC (Cingulate) is a clinical stage biopharmaceutical company that develops new drug products for the treatment of attention deficit and hyperactivity disorder. The company’s pipeline products comprise CTX-1301 and CTX-1302 utilize precision timed release (PTR) drug de …
  • Sequa Corporation:企業の戦略・SWOT・財務情報
    Sequa Corporation - Strategy, SWOT and Corporate Finance Report Summary Sequa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Graham Packaging Company, L.P.:企業の戦略・SWOT・財務情報
    Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report Summary Graham Packaging Company, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bouygues SA (EN):電力:M&Aディール及び事業提携情報
    Summary Bouygues SA (Bouygues) is an industrial group which operates in construction, real estate development, media and telecommunication markets. It undertakes construction contracts for roads, airport runways, seaport, industrial infrastructure, parking areas, recreational facilities, electrical …
  • Bombril SA (BOBR4):企業の財務・戦略的SWOT分析
    Bombril SA (BOBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Aegis Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Aegis Therapeutics LLC (Aegis Therapeutics) is a biotechnology company that research and develops drug delivery and drug formulation technologies. The company commercializes new drug delivery and protein stabilization technologies through product specific licenses to pharmaceutical and bioph …
  • Zoll Medical Corp:企業の戦略的SWOT分析
    Zoll Medical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Complexa Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases. The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s mai …
  • Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) related neurological and psychiatric diseases. Its product portfolio includes antiepileptic drugs a …
  • Cryostar SAS:企業の戦略的SWOT分析
    Cryostar SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Exelon Generation Company LLC:企業の戦略的SWOT分析
    Exelon Generation Company LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Foundation Medicine Inc (FMI)-製薬・医療分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆